Oska Health
Category: AI in Healthcare
An AI-powered hybrid chronic care platform that combines personal health coaches with intelligent algorithms to provide continuous, personalized support for patients managing chronic kidney disease, diabetes, and hypertension between doctor visits. Oska Health was founded in 2022. The company is led by Niklas Best. Based in Frankfurt am Main, Germany. Team size: 11-50. Total funding raised: $14.5M. Latest round: Seed (Feb 2026). Key investors include Capricorn Partners, SwissHealth Ventures, LBBW Venture Capital, BMH Beteiligungs-Managementgesellschaft Hessen, Calm/Storm Ventures, Revent, GoHub Ventures, Aurum Impact.
- Founded
- 2022
- Headquarters
- Frankfurt am Main, Germany
- Team size
- 11-50
- Total funding
- $14.5M
Value proposition
Bridges the care gap between doctor visits by combining human health coaches with AI-powered technology to deliver continuous, personalized chronic care that reduces complications, improves patient outcomes, and decreases healthcare costs while making high-quality chronic care scalable.
Products and solutions
Oska Plus Digital Health App (medical device certified), Personal Health & Nutrition Coaching Platform, AI-Powered Treatment Plan Algorithms, Digital Blood Pressure & Nutrition Diaries, Evidence-Based Remote Health Coaching Program, Physician Integration Platform (no workflow changes required)
Unique value
First-to-market hybrid care model that seamlessly integrates trained human health coaches with AI-supported analysis and digital therapy tools, specifically designed for multimorbid patients managing multiple chronic conditions simultaneously. The platform operates as a certified medical device and requires no changes to physician workflows.
Target customer
Patients with multiple chronic conditions (multimorbid patients), particularly those with chronic kidney disease (CKD), diabetes, and hypertension; statutory health insurance funds across Europe
Industries served
Digital Health, Healthcare AI, Chronic Disease Management, Health Insurance/Payer Services, Telemedicine, Medical Devices
Technology advantage
Proprietary health platform combining intelligent algorithms with behavioral science and medical expertise to personalize treatment recommendations. AI technology supports coaches by reducing administrative burden and enabling scalable high-quality care. Demonstrated clinical effectiveness: 96% patient trust, 92% better health understanding, and 85% healthier lifestyles after 4 months. Platform integrates with existing medical practices without requiring new software adoption.
How they differentiate
First-to-market hybrid care model specifically designed for multimorbid patients managing multiple chronic conditions (CKD, diabetes, hypertension) simultaneously, combining trained human health coaches with AI-supported analysis. Unlike competitors, Oska Health's certified medical device platform requires no changes to physician workflows or new software adoption, while demonstrating strong clinical outcomes.
Main competitors
Kaia Health, HelloBetter, Liva Healthcare
Key partnerships
20+ German statutory health insurance funds, SwissHealth Ventures, Capricorn Partners, LBBW Venture Capital, BMH Beteiligungs-Managementgesellschaft Hessen, Calm/Storm Ventures, 5-HT Digital Hub
Notable customers
20+ German Statutory Health Insurance Funds, KKH Kaufmännische Krankenkasse
Major milestones
Founded in 2022 by experienced healthcare executives from Fresenius Medical Care and DaVita Kidney Care, Secured pre-seed funding of €2.5M in 2023 from LBBW VC, Calm/Storm Ventures, and Hessen Kapital, Achieved partnerships with 20+ German statutory health insurance funds, Raised €11M seed round in February 2026 co-led by Capricorn Partners and SwissHealth Ventures, Certified medical device status for Oska Plus digital health app, Demonstrated clinical effectiveness with 96% patient trust and 85% healthier lifestyle adoption after 4 months
Growth metrics
Partnerships with 20+ German statutory health insurance funds providing 100% cost coverage for insured members; clinical effectiveness demonstrated with 96% patient trust, 92% better health understanding, and 85% healthier lifestyles after 4 months; certified medical device platform (Oska Plus)
Market positioning
Early-stage digital therapeutics challenger in European chronic care management, specifically positioned as the go-to platform for patients with multiple comorbidities in Germany's statutory health insurance system with expansion plans across Europe
Geographic focus
Germany (primary market with 20+ statutory health insurance partnerships), European Union expansion planned
Patents and IP
No registered patents publicly disclosed as of latest update; primary IP protection through proprietary algorithms and medical device certification
About Niklas Best
10 years experience in kidney/renal care industry; former Director of Digital Products at Fresenius Medical Care; serial entrepreneur with 3 founded companies; Executive MBA from University of St. Gallen
Official website: https://www.oska-health.com/